Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 crossover study of Symbicort pMDI vs budesonide in asthmatic children
2010-018316-32Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of budesonide in asthma (5 arms), sponsored by AstraZeneca. Primary endpoint: Primary bronchodilator effect. Started Sep 2010; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on 2010-018316-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018316-32.